Skip to content
★ Sign in to follow
株式会社坪田ラボ logo

株式会社坪田ラボ Stock: price and insider trades · Japan

JP·Mcap JP¥6.7BHealth Care

株式会社坪田ラボ: what insiders have been doing

Every trade that managers of 株式会社坪田ラボ disclose to EDINET (Japan FSA) is tracked on this page. The company sits in the Health Care sector. The last twelve months, up to 26 October 2026, brought 1 filing signed by 1 insider.

No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.

There has been no open-market purchase by an insider of 株式会社坪田ラボ for at least a year.

Compared with its exchange (3,205 companies, median 3 filings), a count of 1 filing is below the norm. Over the whole record (from 2022), the tally stands at no purchases and 2 sales.

Source: insider filings from EDINET (Japan FSA). Past trades are no guide to future returns.

Insider Decl.
16
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
€5M
2 ops. · all time

This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.

Fundamental score
Ranked 21,502 of 26,911 companies
30.8
score / 100
Value
17
Quality
45
FCF yld-8.8%
Earn yld-11%
EV/EBITDA·
ROE-65%
Gross mgn66%
Net mgn·
Debt/EBITDA·
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2026

FY ended March 2026 · cache

JP¥258
Analyst consensus
·
Income statement
RevenueJP¥200M
Gross profitJP¥131.6M66% margin
EBITDA-JP¥739.2M-370% margin
Net income-JP¥761.8M-177.6% margin
Valuation
P/Book9.1x
Beta1.21
Balance sheet & cash
Market capJP¥6.7B
Total debtJP¥69.2M
Free Cash Flow-JP¥586.6M
Debt / Equity9%
Profitability & ownership
ROE-65.3%
ROA-27.8%
% insiders71.6%
% institutions1.7%
Last declaration on 19 June 2026
Declarations16 total
  • ●
    Large shareholderExecutives
    13EDINET
    100.0% of flowShareXTKSEDINET:S100YF9Z
  • ●
    OfficerExecutives
    13EDINET
    20.7% of flowShareXTKSEDINET:S100WMMF
  • ●
    OfficerExecutives
    13EDINET
    20.7% of flowShareXTKSEDINET:S100WM4X
  • ●
    Large shareholderExecutives
    0EDINET
    ShareXTKSEDINET:S100WLPE
  • ●
    Large shareholderExecutives
    7EDINET
    22.3% of flowShareXTKSEDINET:S100UHS0
  • ●
    Large shareholderExecutives
    7EDINET
    22.4% of flowShareXTKSEDINET:S100RPDK
  • ●
    Large shareholderExecutives
    6EDINET
    13.9% of flowShareXTKSEDINET:S100Q04R
  • ●
    Unknown
    Large shareholderExecutives
    10EDINET
    50.2% of flowShareXTKSEDINET:S100ORPI
  • ▼
    Unknown
    Large shareholderExecutives
    249M JPY9EDINET
    576,000 shares@ JP¥432.4036.8% of flowShareXOFFEDINET:S100ORPI:T2
  • ●
    Unknown
    OfficerExecutives(filed)
    11EDINET
    0.0% of flowShareXTKSEDINET:S100ON58
  • ●
    Unknown
    OfficerExecutives(filed)
    16EDINET
    49.5% of flowShareXTKSEDINET:S100ON51
  • ●
    Unknown
    Large shareholderExecutives(filed)
    10EDINET
    49.8% of flowShareXTKSEDINET:S100OFOV
  • ▼
    Unknown
    Large shareholderExecutives
    432M JPY11EDINET
    1,000,000 shares@ JP¥432.399963.2% of flowShareXOFFEDINET:S100OFOV:T1
  • ●
    Unknown
    Large shareholderExecutives(filed)
    5EDINET
    0.0% of flowShareXTKSEDINET:S100OGW2
  • ●
    Unknown
    Large shareholderExecutives(filed)
    5EDINET
    0.0% of flowShareXTKSEDINET:S100O8I3
  • ●
    Unknown
    Large shareholderExecutives(filed)
    10EDINET
    50.4% of flowShareXTKSEDINET:S100O7Z1

16 of 16 declarations

About 株式会社坪田ラボ

Tsubota Lab Co., Ltd. is a Japanese company specializing in the healthcare and pharmaceutical sector. It is listed on the XTKS market.